"Designing Growth Strategies is in our DNA"
The U.S. ambulatory surgical centers market size was valued at USD 43.70 billion in 2022. The market is projected to grow from USD 46.62 billion in 2023 to USD 75.20 billion by 2030, exhibiting a CAGR of 7.1% during the forecast period.
Ambulatory Surgical Centers (ASCs) refer to innovative outpatient healthcare centers offering surgical services, such as preventive and diagnostic services on the same day. These settings offer a comfortable ambience and affordable services compared to most hospitals in the U.S. The specialty services offered by these settings include surgeries related to orthopedics, pain management, ophthalmology, gastroenterology, dermatology, and urology.
The market’s growth is mainly attributed to the increasing need for new solutions and innovations to cut down healthcare costs in the U.S. Moreover, the growing incidence of chronic diseases requiring surgeries is driving the market growth. Furthermore, rising investments, a shift in patients’ admission from hospitals to ambulatory surgical centers, and favorable reimbursement scenarios are propelling market progress. Additionally, the increasing number of these centers over the last decade will drive the market outlook.
Decline in Surgeries During COVID-19 Pandemic Reduced Market Revenue
The COVID-19 pandemic had a negative influence on the market. Challenges, such as shortage of workforce, procedural prioritization, risk of transmission of COVID-19 virus, and the limited number of surgical procedures in these settings, challenged the market’s growth during this period. ASCs in the U.S. witnessed a decline in the number of visits, thereby reducing the overall revenue of ambulatory settings. Moreover, operational restrictions, such as mandates to stop or postpone elective surgeries during the COVID-19 pandemic, negatively impacted the market.
Additionally, factors including the rapid spread of the COVID-19 pandemic through public gatherings and conserving vital resources, such as personal protective equipment and mechanical ventilators, postponed the elective surgical procedures in these settings in 2020. However, the migration of patients from hospitals to ambulatory surgical centers is expected to be rapid post the COVID-19 outbreak. The resumption of elective procedures also increased the patient volume in 2021 and helped the market recover partially and reach to the pre-pandemic level. In the same year, the substantial increase in the revenue of ambulatory settings due to increased patient visits also contributed to the surge in the market’s growth. Furthermore, in 2022, the U.S. ambulatory surgical centers market was fully recovered and bounced back to its pre-pandemic level of growth.
Strategic Mergers & Acquisitions to Determine Market’s Growth Trajectory
One of the most important trends witnessed in this market in the U.S. is that there has been an increased focus on strategic mergers and acquisitions. Companies operating in this market are constantly focusing on several strategies, such as mergers, acquisitions, and business expansions. These strategies will help them increase their revenue, thereby fostering the market’s growth.
Similarly, many market players are involved in developing new and innovative solutions in ambulatory settings, which is expected to boost the U.S. ambulatory surgical centers market growth.
Request a Free sample to learn more about this report.
Growing Preference for Ambulatory Surgical Centers over Hospitals to Drive Market Growth
The gradual shift of surgical procedures from hospitals to these surgical centers is driving the market growth. The volume of surgeries being performed in ASCs has observed a major increase in the last few years. Moreover, a large number of patients preferring these settings for various orthopedic surgeries will also drive market growth. Factors such as shorter stays, use of innovative & new technologies in ambulatory settings, cost-effective surgical procedures, and fewer risks of infection will also boost the volume of surgeries in these settings.
Additionally, several benefits of these settings over hospitals are contributing to the market growth. These benefits include lower waiting time and less time taken to complete a surgical procedure. Furthermore, increasing investments in developing new ASCs is expected to drive the U.S. ambulatory surgical centers market growth during the forecast period.
Positive Reimbursement Scenario for Procedures in ASCs to Boost Market Growth
The availability of reimbursements for ASC procedures is one of the critical drivers for the market’s growth. The introduction of favorable policies for reimbursement are prompting the Centers for Medicare & Medicaid Services (CMS) to increase its list of surgeries that can be conducted in ASCs. Moreover, rising initiatives by commercial payers to encourage physicians to perform various surgical procedures in these settings are expected to drive market growth in the coming years. Furthermore, CMS constantly focuses on reviewing the complications associated with performing surgeries in these settings, thereby improving the safety of patients undergoing operations in ASCs.
Such intense focus of payers on the safety of surgical procedures in ambulatory settings can attract a large patient pool in the U.S. Thus, these factors are expected to propel market growth in the future.
Several Disadvantages of ASCs to Limit Market Growth
A large patient pool in the U.S. is opting for outpatient surgical centers to undergo surgery over the past few years. However, several disadvantages of these settings might limit market growth during the forecast timeframe. These disadvantages include a shortage of facilities for overnight stay, complications & emergencies during surgical procedures, and no plans for contingencies. The difficulties in some surgeries may need the transfer of patients from ASCs to hospitals nearby. Thus, some of the patients opt for hospitals over ASCs to undergo surgery.
The common complications encountered during surgical procedures in ambulatory settings include pain & nausea, impaired healing, and a higher risk of infections. Thus, such disadvantages of these settings are expected to hamper market growth during the forecast period.
Single-specialty Segment to Hold a Dominant Share Due to Growing Cases of Ophthalmic Disorder
Based on type, the market is segmented into single-specialty and multi-specialty.
The single-specialty segment dominated the U.S. market in 2022 and is anticipated to continue its dominance during the forecast period. The dominance is attributed to the growing incidence of ophthalmic disorders and the strong presence of single-specialty ambulatory surgical centers in the U.S.
The multi-specialty segment is projected to record a substantial CAGR during the forecast period. Factors such as the increasing number of surgical procedures related to ophthalmology, gastroenterology, and pain management are expected to boost the segment’s growth in the coming years.
To know how our report can help streamline your business, Speak to Analyst
Physician-owned Segment Leads Market Owing to Efficient Services in these Centers
Based on ownership, the market is segmented into hospital-owned, physician-owned, and corporate-owned.
The physician-owned segment accounted for the largest U.S. ambulatory surgical centers market share in 2022 and is expected to register a substantial CAGR in the coming years. Physician-owned ambulatory centers are quite common, as doctors own 100% equity in these surgical centers. The segment’s large share is attributed to factors, including physicians’ convenience while scheduling surgeries and increasing inclination toward this type of ownership by physicians in the U.S.
The corporate-owned segment is anticipated to record the highest CAGR during the forecast period of 2023-2030. The segment’s high growth rate is attributed to the increasing focus of management companies and physicians on forming a common joint venture. This ownership model is expected to gain popularity in the coming years as partnerships between corporate firms and physicians are emerging.
Surgical Services Segment to Continue its Dominance Due to Increasing Number of Surgical Procedures
Based on application, the market is segmented into surgical services and diagnostic services.
The surgical services segment dominated the market in 2022 and is expected to register the highest CAGR during the forecast timeframe. This segment's large share and high growth rate are attributed to the increasing number of surgical procedures in ambulatory settings. These procedures majorly include surgeries related to pain management, gastroenterology, ophthalmology, and orthopedics.
The diagnostic services segment is estimated to record a moderate CAGR during the forecast period. The growth of this segment is attributed to the increasing number of patients opting for various diagnostic services in ambulatory settings. These diagnostic services include diagnostic colonoscopy and colorectal screening.
Based on geography, the market has been studied across the West U.S., South U.S., Middle West U.S., and Northeast U.S.
In 2022, the South U.S. held the highest share of the market. The market’s growth in this region is attributed to the strong presence of market players providing ambulatory services, a large patient pool requiring various surgical procedures, and an increasing number of ambulatory surgical centers in Alabama, Texas, and North Carolina.
West U.S. accounted for a significant share of the market. The growth of this region is attributed to the rising number of ambulatory surgical centers and the rising focus of market players in the transition of outpatient surgery departments to ASCs.
Middle West U.S. and Northeast U.S. are expected to grow at moderate CAGR during the forecast period. The rising number of procedures in orthopedics & gastroenterology, rising players’ initiatives, and the strong presence of ASCs in New Jersey, Pennsylvania, Illinois, Indiana, and Ohio and New York are expected to boost market growth during the forecast timeframe.
TH Medical to Hold Key Market Share in 2022 Due to Vast ASC Chains
The market is highly fragmented due to the presence of many companies offering ambulatory surgical services in the U.S. However, several key players, such as TH Medical, Surgery Partners, AMSURG (Kohlberg Kravis Roberts & Co. L.P.), and Surgical Care Affiliates, held a substantial share of the market in 2022.
TH Medical dominated the market in 2022. Its dominance is due to the large number of ambulatory surgical centers owned and operated by the company. For instance, according to the recently published data by VMG Health, in 2022, TH Medical owned and operated 440 ambulatory surgical centers.
Other companies, such as Constitution Surgery Alliance, SurgCenter, and Medical Facilities Corporation held substantial market shares due to their strong presence in the U.S. and the number of ASCs owned by them. Furthermore, strategic initiatives, such as mergers and acquisitions, are expected to increase their market shares in the coming years.
An Infographic Representation of U.S. Ambulatory Surgical Centers Market
To get information on various segments, share your queries with us
The report provides a detailed analysis of the market. It focuses on key aspects, such as leading companies, types, ownerships, and applications. Besides this, it offers insights into the latest market trends and highlights key industry developments. In addition to the factors mentioned above, the report includes the number of ASCs in key states, an overview of top surgical procedures in ambulatory settings, a comparative analysis of the average price and cost of elective procedures in ASCs & HOPDs, and analysis of the COVID-19 impact on the market.
ATTRIBUTE | DETAILS |
Study Period | 2019-2030 |
Base Year | 2022 |
Estimated Year | 2023 |
Forecast Period | 2023-2030 |
Historical Period | 2019-2021 |
Growth Rate | CAGR of 7.1% from 2023-2030 |
Unit | Value (USD Billion) |
Segmentation | By Type
|
By Ownership
| |
By Application
| |
By Region
|
Fortune Business Insights says that the U.S. market value stood at USD 43.70 billion in 2022 and is projected to reach USD 75.20 billion by 2030.
The market is expected to exhibit a steady CAGR of 7.1% during the forecast period of 2023-2030.
By type, the single-specialty segment leads the market and held the largest share in 2022.
The increasing shift of surgical procedures from hospitals to ASCs, presence of reimbursement policies, growing demand for advanced treatments, increasing investments, and rising incidence of various diseases related to ophthalmology, gastroenterology, pain management, and orthopedics are the key factors driving the markets growth.
TH Medical, Surgery Partners, AMSURG (Kohlberg Kravis Roberts & Co. L.P.), and Surgical Care Affiliates are the top players in the market.
US +1 833 909 2966 ( Toll Free )